CHINA PHARMA HOLDINGS, INC. Proceeds from Construction Loans Payable
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Proceeds from Construction Loans Payable of -$145.18 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConstructionLoansPayable · last filed 2017-05-11
- CHINA PHARMA HOLDINGS, INC. proceeds from construction loans payable for the quarter ending 2017-03-31 was -$145.18K.
- CHINA PHARMA HOLDINGS, INC. proceeds from construction loans payable for the quarter ending 2016-12-31 was -$3.03M.
- CHINA PHARMA HOLDINGS, INC. proceeds from construction loans payable for the quarter ending 2016-09-30 was $1.21M.
- CHINA PHARMA HOLDINGS, INC. proceeds from construction loans payable for the quarter ending 2016-06-30 was $611.86K.
- CHINA PHARMA HOLDINGS, INC. proceeds from construction loans payable for fiscal 2016 was -$1.51M.
- CHINA PHARMA HOLDINGS, INC. proceeds from construction loans payable for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- CHINA PHARMA HOLDINGS, INC. proceeds from construction loans payable for fiscal 2014 was $605.00K, a 95.09% decline from fiscal 2013.
- CHINA PHARMA HOLDINGS, INC. proceeds from construction loans payable for fiscal 2013 was $12.32M.
| Period end | Proceeds from Construction Loans Payable 3 month | Proceeds from Construction Loans Payable 3 month as first filed | Proceeds from Construction Loans Payable 6 month | Proceeds from Construction Loans Payable 9 month | Proceeds from Construction Loans Payable 12 month |
|---|---|---|---|---|---|
| 2017-03-31 | -$145.18K 10-Q · filed 2017-05-11 | -$3.17M derived: sum of 2 quarters · filed 2017-05-11 | -$1.96M derived: sum of 3 quarters · filed 2017-05-11 | -$1.34M derived: sum of 4 quarters · filed 2017-05-11 | |
| 2016-12-31 | -$3.03M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | -$1.81M derived: sum of 2 quarters · filed 2017-03-31 | -$1.20M derived: sum of 3 quarters · filed 2017-03-31 | -$1.51M 10-K · filed 2017-03-31 | |
| 2016-09-30 | $1.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $1.83M derived: sum of 2 quarters · filed 2016-11-14 | $1.52M 10-Q · filed 2016-11-14 | $1.52M derived: sum of 4 quarters · filed 2017-05-11 | |
| 2016-06-30 | $611.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $306.03K 10-Q · filed 2016-08-11 | $306.03K derived: sum of 3 quarters · filed 2017-05-11 | $306.03K derived: sum of 4 quarters · filed 2017-05-11 | |
| 2016-03-31 | -$305.83K 10-Q · filed 2017-05-11 | $305.83K 10-Q · filed 2016-05-16 | -$305.83K derived: sum of 2 quarters · filed 2017-05-11 | -$305.83K derived: sum of 3 quarters · filed 2017-05-11 | -$305.83K derived: sum of 4 quarters · filed 2017-05-11 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $0.00 derived: sum of 2 quarters · filed 2017-03-31 | $0.00 derived: sum of 3 quarters · filed 2017-03-31 | $0.00 10-K · filed 2017-03-31 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 | $246.00 derived: sum of 4 quarters · filed 2016-11-14 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $0.00 10-Q · filed 2016-08-11 | $246.00 derived: sum of 3 quarters · filed 2016-08-11 | -$345.00 derived: sum of 4 quarters · filed 2016-08-11 | |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-16 | $246.00 derived: sum of 2 quarters · filed 2016-05-16 | -$345.00 derived: sum of 3 quarters · filed 2016-05-16 | -$2.73K derived: sum of 4 quarters · filed 2016-05-16 | |
| 2014-12-31 | $246.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$345.00 derived: sum of 2 quarters · filed 2016-03-30 | -$2.73K derived: sum of 3 quarters · filed 2016-03-30 | $605.00K 10-K · filed 2016-03-30 | |
| 2014-09-30 | -$591.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-12-28 | -$2.98K derived: sum of 2 quarters · filed 2015-12-28 | $604.76K 10-Q · filed 2015-12-28 | $6.49M derived: sum of 4 quarters · filed 2015-12-28 | |
| 2014-06-30 | -$2.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-28 | $605.35K 10-Q · filed 2015-12-28 | $6.49M derived: sum of 3 quarters · filed 2015-12-28 | $12.93M derived: sum of 4 quarters · filed 2015-12-28 | |
| 2014-03-31 | $607.73K 10-Q · filed 2015-12-28 | $6.49M derived: sum of 2 quarters · filed 2015-12-28 | $12.93M derived: sum of 3 quarters · filed 2015-12-28 | ||
| 2013-12-31 | $5.88M derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-28 | $12.32M derived: sum of 2 quarters · filed 2015-12-28 | $12.32M 10-K · filed 2015-12-28 | ||
| 2013-09-30 | $6.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $6.44M 10-Q · filed 2013-11-14 | |||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-14 | ||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | $0.00 10-K · filed 2014-03-20 | |||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |